restless legs syndrome


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

restless legs syndrome

n.
A neurological disorder characterized by an uncontrollable urge to move the legs, usually as a result of uncomfortable sensations such as tingling or aching. It is usually worse in the evening and night and during periods of inactivity, and it often interferes with sleep. Also called Willis-Ekbom disease.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.restless legs syndrome - feeling of uneasiness and restlessness in the legs after going to bed (sometimes causing insomnia); may be relieved temporarily by walking or moving the legs
syndrome - a pattern of symptoms indicative of some disease
References in periodicals archive ?
Restless legs syndrome (RLS) is a progressive and chronic disorder manifested by a burning sensation and paresthesia, and is characterized by a requirement of moving the affected extremities when at rest and during the night (Allen et al, 2003; American Sleep Disorders Association, 1997; Walters, 1995).
The aim of the study was to assess the prevalence of restless legs syndrome (RLS) in MS patients and RLS relationship with patient age, sex, degree of disability, form of MS, time elapsed from MS diagnosis and use of antidepressants.
Objective: To find and compare prevalence and severity of Restless Legs Syndrome among physiotherapy students.
Restless legs syndrome (RLS) is characterized by an irresistible urge to move the legs, usually accompanied by an abnormal sensation.
Restless legs syndrome (RLS) is a neurological movement disorder that affects a large number of people (1).
Keywords: Restless legs syndrome, Polysomnography, Sleep disorder.
XenoPort's marketed offerings include lead product Horizant (gabapentin enacarbil), a drug indicated for moderate-to-severe primary restless legs syndrome and postherpetic neuralgia, and Regnite (gabapentin enacarbil) extended-release tablets, which have received approval in Japan and also indicated for moderate-to-severe primary restless legs syndrome.
Canadian patients suffering from Restless Legs Syndrome will have access to Relaxis, a medical device approved by the US Food and Drug Administration for treating the symptoms of primary RLS, due to an exclusive new agreement between Sleep Therapeutics and Sensory NeuroStimulation Inc.
Thirty patients (aged 20-80 years; mean age, 56 years) with restless legs syndrome and a low-normal serum ferritin level (15-50 ng/ml; suggestive of low or borderline-low iron status) were randomly assigned to receive ferrous sulfate (325 mg twice a day) or pramipexole (0.
The aim of this study was to investigate whether high-frequency rTMS could have any beneficial effects in restless legs syndrome (RLS).
It also reviews key players involved in the therapeutic development for Restless Legs Syndrome and special features on late-stage and discontinued projects.
Allen, "Iron and the restless legs syndrome," Sleep, vol.